Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-036262
Filing Date
2019-06-11
Accepted
2019-06-11 19:22:07
Documents
1
Period of Report
2019-06-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3865
  Complete submission text file 0001209191-19-036262.txt   5220
Mailing Address 2200 SUNBURST STREET CHATSWORTH CA 90401
Business Address
Wysenski Nancy (Reporting) CIK: 0001294596 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35837 | Film No.: 19892209

Mailing Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472
Business Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472 617.715.3600
TETRAPHASE PHARMACEUTICALS INC (Issuer) CIK: 0001373707 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations